The Study of Monitoring and Dosing Guidance of Direct Oral Anticoagulants Based on Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics

RecruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

October 30, 2026

Study Completion Date

January 30, 2027

Conditions

Pulmonary Embolism

Interventions

DRUG

Rivaroxaban

Trial Locations (1)

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

collaborator

Ruijin Hospital

OTHER

collaborator

Xiangya Hospital of Central South University

OTHER

collaborator

China-Japan Friendship Hospital

OTHER

lead

Peking Union Medical College Hospital

OTHER